Corticotropin-releasing factor 1 receptor antagonists: a patent review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Corticotropin-releasing factor 1 receptor antagonists: a patent review
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 23, Issue 8, Pages 1057-1068
Publisher
Informa Healthcare
Online
2013-05-04
DOI
10.1517/13543776.2013.795545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis and structure–activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists
- (2012) Kunitoshi Takeda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis, and structure–activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists
- (2012) Kunitoshi Takeda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Something's got to give: psychiatric disease on the rise and novel drug development on the decline
- (2012) Daniel J. Chandler DRUG DISCOVERY TODAY
- Design, Synthesis, and Structure–Activity Relationships of Novel Pyrazolo[5,1-b]thiazole Derivatives as Potent and Orally Active Corticotropin-Releasing Factor 1 Receptor Antagonists
- (2012) Yoshinori Takahashi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF1) receptor antagonists
- (2011) Tetsuji Saito et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists
- (2011) Tetsuji Saito et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists
- (2011) Tetsuji Saito et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profiles
- (2011) Duncan C. Miller et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Corticotropin releasing factor receptor antagonists for major depressive disorder
- (2011) Marcelo Paez-Pereda et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Update on Corticotropin-Releasing Factor Pharmacotherapy for Psychiatric Disorders: A Revisionist View
- (2011) George F Koob et al. NEUROPSYCHOPHARMACOLOGY
- Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
- (2010) Vladimir Coric et al. DEPRESSION AND ANXIETY
- Progress in corticotropin-releasing factor-1 antagonist development
- (2010) Eric P. Zorrilla et al. DRUG DISCOVERY TODAY
- A Strategy to Minimize Reactive Metabolite Formation: Discovery of (S)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist†
- (2009) Richard A. Hartz et al. JOURNAL OF MEDICINAL CHEMISTRY
- A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1Antagonist) in the Treatment of Major Depression
- (2008) Brendon Binneman et al. AMERICAN JOURNAL OF PSYCHIATRY
- 2-Arylpyrimidines: Novel CRF-1 receptor antagonists
- (2008) Taeyoung Yoon et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search